Addus HomeCare ADUS
$122.50 +$1.43 (+1.18%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $122.50 0.00%
Open$121.25
Prev close$121.07
Day range$119.26 – $123.29
Volume254.3K
Market cap$2.28B
P/E (TTM)20.4
Dividend yield–
ADUS Stock News
Headlines matching Addus HomeCare or the ADUS ticker, most recent first.
- Raymond James Maintains Addus HomeCare(ADUS.US) With Buy Rating, Announces Target Price $137
- BMO Capital Maintains Addus HomeCare(ADUS.US) With Hold Rating, Raises Target Price to $115 Positive
- Truist Financial Maintains Addus HomeCare(ADUS.US) With Buy Rating
- BofA Securities Downgrades Addus HomeCare(ADUS.US) to Hold Rating, Announces Target Price $125 Negative
- William Blair Maintains Addus HomeCare(ADUS.US) With Buy Rating
- RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Raises Target Price to $134 Positive
- A Quick Look at Today's Ratings for Addus HomeCare(ADUS.US), With a Forecast Between $96 to $135
- Barclays Maintains Addus HomeCare(ADUS.US) With Sell Rating, Maintains Target Price $96
- Barclays Maintains Addus HomeCare(ADUS.US) With Sell Rating, Raises Target Price to $96 Positive
- UBS Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $145
- TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Maintains Target Price $131
- RBC Capital Maintains Addus HomeCare(ADUS.US) With Buy Rating, Cuts Target Price to $130 Negative
- TD Cowen Maintains Addus HomeCare(ADUS.US) With Buy Rating, Cuts Target Price to $131 Negative
- Analysts' Top Healthcare Picks: Addus Homecare (ADUS), Aardvark Therapeutics, Inc. (AARD)
- Raymond James Initiates Addus HomeCare(ADUS.US) With Buy Rating
No comments yet — be the first to weigh in on ADUS.
Sign in to join the discussion.